Menu

Global Real World Evidence Solutions Market Size, Share, Trends, Industry Statistics Report, By Component (Dataset (Claims, Clinical, Pharmacy, Patient), Services); By Therapeutic Area (Oncology, Cardiovascular, Immunology); By End User (Pharmaceuticals, Medical Devices, Payers, Providers); Regional Analysis (North America - U.S, Canada, Other) (Asia-Pacific - India, Japan, China, South Korea, Japan, Australia, and Other) (Europe - U.K., Germany, Netherlands, Lithuania, Austria, Belgium, Poland, Sweden, Spain, France, Russia and Other) (Middle East - Saudi Arabia, UAE and Africa - South Africa, Zimbabwe and RoW) - Global Industry Insights, Trends and Forecast, 2019-2025

Report Format : PDF
Published Date : Oct-2018
Pages : 187
Report ID : VSR001342

Global Real World Evidence Solutions Market Size is estimated to expand rapidly in coming years, at a CAGR of 13.6 % from 2018 to 2025. In 2017, the global market valuation was USD 0.62 billion, and it is anticipated to be greater than USD xx.xx billion by 2025. The real-world industry for evidentiary alternatives will grow rapidly as production is shifted towards value-based treatment, the workforce has increased aging and acute disease incidence, and medication production costs, and production costs are subsequently rising.

Pharmaceutical companies borrow several years to launch a fresh drug molecule, and they are investing billions with small probability of achievement in research and development. To cut drug development periods, pharmaceutical research centers, contrasted with few client rooms in clinical trials, need definite insights into therapy choices in a wider population. The use of real-world information (RWE) is increasingly evident when pharmaceutical and biotech businesses recognize that RWE can be essential for medication growth and life cycle governance, as well as enhancing innovation and price effectiveness for clinical studies. Geographically, North America has accounted for largest share in the global market of real world evidence solutions.

Global Market Growth Opportunities (Revenue, Growth) By 2017-2025

Global Real World Evidence Solutions Market Size, Share, Trends, Industry Statistics Report

This global market study report analysis offers in-depth insights, revenue details, and other vital information regarding the global real world evidence solutions market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2025. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global real-world evidence solutions market report has been segmented on the basis of type, application, and region. It includes the estimation of the market size, in terms of value, with respect to 4 main geographies, namely, North America, Europe, APAC, and RoW.

Segment Analysis

By Therapeutic Area Insights: On the basis of the therapeutic area, global real world evidence solutions market has been segmented into oncology, cardiovascular, immunology. In 2018, the oncology section was the biggest market share. The elevated proportion of the clinical oncology studies and the increasing incidence of cancer globally can be ascribed to the big percentage of this section.

By End User Insights: On the basis of end-user, global real-world evidence solutions market has been segmented into pharmaceuticals, medical devices, payers, and providers. The pharmaceutical and medical equipment sector in 2018 represented the market's biggest proportion. The big proportion of this section can be ascribed to the growing significance of RWE surveys for drug approval, the need for expensive drug retrieval prevention and the growing need for a real-world assessment of drug efficiency.

Regional Analysis

The real-world evidence solutions market is divided into regions that are North America - U.S, Canada, Other; Asia-Pacific -India, Japan, China, Australia, Other; Europe - UK, Russia, France, Brazil, Other; Middle East and Africa. Every region analysis details in sense of growth, revenue, volume, challenges, and opportunities with the regional and global key players. The biggest share of the real world probation market was accounted for in North America. A favorable regulatory environment has existed, with the presence of a large number of RWE service providers and of an established pharmaceutical industry in the region, along with the high R&D expenditure, which accounts for North America's major share in the global real-world evidence market.

China, which is one of the major variables increasing the requirement for reliable proof services industry in the APAC area, is anticipated to dominate the APAC industry due to strong supply in its clinical research operations. The European market for real world evidence solutions is expected to witness significant growth in forecast period. 

Global Real World Evidence Solutions Market Size, Share Analysis by Region 2017

Global Real World Evidence Solutions Market Size, Share, Trends, Industry Statistics Report

Global Real World Evidence Solutions Market Study Objective

1. To forecast the market size of real world evidence solutions market, along with describing and defining the market, in terms of volume and revenue as well as market opportunities for stakeholders, in order to provide a competitive landscape for global market players.

2. Market analysis and forecast of real world evidence solutions market on the basis of region, substrate, and application or end-use industry. To profile major market players, and to analyze their market shares and essential competencies comprehensively.

3. To analyze and elaborate on significant factors that will have a major impact on the growth of real world evidence solutions market, such as drivers, restraints, challenges, and opportunities.

4. The regional analysis of real-world evidence solutions market, to induce market size of five global major regions, which include, Europe, North America, South America, Middle East & Africa, and the Asia Pacific.

5. Strategic analysis of micro-markets, in terms of individual prospects, opportunities, growth trends and their involvement in the overall market.

6. To provide detailed analysis of competitive and strategic developments in the real world evidence solutions market like a new product launch, partnership & agreement, investment & expansion, and company merger & acquisitions.

Key Players Landscape

Anthem, Clinigen Group, Cognizant, IBM Corporation, ICON, IQVIA, Optum, OracleCorporation, PAREXEL International Corporation, PerkinElmer, Pharmaceutical Product Development, SAS Institute, and Syneos Health are some of the key players in the market of real-world evidence solutions.

Global Real World Evidence Solutions Market Study Report Offer You!

The global real-world evidence solutions market study report gives an idea about market size, share, stock, equity, investment and total price analysis. Also, the report provides comprehensively industry insights with all major factors such as market credit, allocation, demand, distribution, market scope, key players, end-user & applications, provisions, livestock, commodities and industry economics analysis, future growth & forecast. The global market report includes all depth data like pre-market emphasis, market survey, market investment, industry advice, portfolio, finance, access, trade, market exploration, industry review and market predication & projection to develop effective strategies for optimizing their market position.

Enquiry for Table of Content

Global Real World Evidence Solutions Market Size, Share, Trends, Industry Statistics Report, By Component (Dataset (Claims, Clinical, Pharmacy, Patient), Services); By Therapeutic Area (Oncology, Cardiovascular, Immunology); By End User (Pharmaceuticals, Medical Devices, Payers, Providers); Regional Analysis (North America - U.S, Canada, Other) (Asia-Pacific - India, Japan, China, South Korea, Japan, Australia, and Other) (Europe - U.K., Germany, Netherlands, Lithuania, Austria, Belgium, Poland, Sweden, Spain, France, Russia and Other) (Middle East - Saudi Arabia, UAE and Africa - South Africa, Zimbabwe and RoW) - Global Industry Insights, Trends and Forecast, 2019-2025

Enquiry for Methodology

Global Real World Evidence Solutions Market Size, Share, Trends, Industry Statistics Report, By Component (Dataset (Claims, Clinical, Pharmacy, Patient), Services); By Therapeutic Area (Oncology, Cardiovascular, Immunology); By End User (Pharmaceuticals, Medical Devices, Payers, Providers); Regional Analysis (North America - U.S, Canada, Other) (Asia-Pacific - India, Japan, China, South Korea, Japan, Australia, and Other) (Europe - U.K., Germany, Netherlands, Lithuania, Austria, Belgium, Poland, Sweden, Spain, France, Russia and Other) (Middle East - Saudi Arabia, UAE and Africa - South Africa, Zimbabwe and RoW) - Global Industry Insights, Trends and Forecast, 2019-2025

Single User: $4,999
Multi User: $6,999
Enterprice Licence: $8,999

Get 15% Discount

Why Choose Veracious Statistics Research ?

Save Your Time

Cost-Effective Services

Wide Range of Reports

World Class Market Research

100% Customer Satisfaction

24/7 Customer care Support

Any more questions?

Get in touch with us quickly and easily. We are happy to help!

Contact us

Sales Shaulova

Global Operations Manager +1-937-947-0908 Mon - Fri - 24/7/

Let's Talk Online